HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
-8.17%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$116M
AUM Growth
+$116M
(-46%)
Cap. Flow
-$86.8M
Cap. Flow
% of AUM
-75.1%
Top 10 Holdings %
Top 10 Hldgs %
48.45%
Holding
168
New
35
Increased
13
Reduced
60
Closed
55
Top Buys
| 1 |
RP
RealPage, Inc.
RP
|
$3.18M |
| 2 |
IDTI
Integrated Device Technology I
IDTI
|
$2.75M |
| 3 |
RHT
Red Hat Inc
RHT
|
$2.75M |
| 4 |
DNB
Dun & Bradstreet
DNB
|
$2.73M |
| 5 |
NFX
Newfield Exploration
NFX
|
$2.3M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
$18.3M |
| 2 |
COL
Rockwell Collins
COL
|
$16.1M |
| 3 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
$13M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
$5.42M |
| 5 |
Visa
V
|
$4.83M |
Sector Composition
| 1 | Communication Services | 22.93% |
| 2 | Healthcare | 16.45% |
| 3 | Technology | 10.96% |
| 4 | Consumer Discretionary | 7.41% |
| 5 | Real Estate | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
John Wiley & Sons Class A
WLY
$2.12B
| $277K | 0.24% |
5,900
-1,600
| -21% | -$75.1K |
|
77
AbbVie
ABBV
$374B
| $277K | 0.24% |
+3,000
| New | +$277K |
|
|
BSMX
78
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $275K | 0.24% |
44,600
+33,500
| +302% | +$207K |
|
79
Pfizer
PFE
$141B
| $262K | 0.23% |
6,000
-4,800
| -44% | -$210K |
|
|
VIAB
80
DELISTED
Viacom Inc. Class B
VIAB
| $260K | 0.22% |
10,100
-4,100
| -29% | -$106K |
|
|
PARA
81
DELISTED
Paramount Global Class B
PARA
| $258K | 0.22% |
+5,900
| New | +$258K |
|
82
Bread Financial
BFH
$3.07B
| $255K | 0.22% |
1,700
-500
| -23% | -$75.1K |
|
83
Chemed
CHE
$6.7B
| $255K | 0.22% |
+900
| New | +$255K |
|
84
UnitedHealth
UNH
$279B
| $249K | 0.22% |
1,000
-700
| -41% | -$174K |
|
|
HRC
85
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $248K | 0.21% |
+2,800
| New | +$248K |
|
86
Bruker
BRKR
$4.45B
| $244K | 0.21% |
+8,200
| New | +$244K |
|
87
HCA Healthcare
HCA
$95.4B
| $236K | 0.2% |
+1,900
| New | +$236K |
|
88
Elevance Health
ELV
$72.4B
| $236K | 0.2% |
900
-800
| -47% | -$210K |
|
89
Universal Health Services
UHS
$11.6B
| $233K | 0.2% |
2,000
-1,700
| -46% | -$198K |
|
90
Quest Diagnostics
DGX
$20.1B
| $233K | 0.2% |
2,800
-1,500
| -35% | -$125K |
|
91
Humana
HUM
$37.5B
| $229K | 0.2% |
800
-600
| -43% | -$172K |
|
92
Cigna
CI
$80.2B
| $228K | 0.2% |
1,200
-1,200
| -50% | -$228K |
|
93
Encompass Health
EHC
$12.5B
| $222K | 0.19% |
3,600
-2,200
| -38% | -$136K |
|
94
Centene
CNC
$14.8B
| $219K | 0.19% |
+1,900
| New | +$219K |
|
95
Aflac
AFL
$57.1B
| $219K | 0.19% |
4,800
-3,200
| -40% | -$146K |
|
96
AGNC Investment
AGNC
$10.4B
| $217K | 0.19% |
12,400
-7,600
| -38% | -$133K |
|
97
Cencora
COR
$57.2B
| $216K | 0.19% |
2,900
-2,500
| -46% | -$186K |
|
98
Caterpillar
CAT
$194B
| $216K | 0.19% |
1,700
+300
| +21% | +$38.1K |
|
99
Jazz Pharmaceuticals
JAZZ
$7.99B
| $211K | 0.18% |
+1,700
| New | +$211K |
|
100
Reinsurance Group of America
RGA
$13B
| $210K | 0.18% |
1,500
-1,100
| -42% | -$154K |
|